Investors

Corporate Profile

Genetron Holdings Limited (“Genetron Health” or the “Company”) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.

Latest Quarterly Results

Events & Presentations
SEC Filings
Filing date Form Description View
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

View HTML
20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Print Page
RSS
Contact IR
Search